Thrombophlebitis in pregnancy.

Am J Nurs

Published: January 1980

Download full-text PDF

Source

Publication Analysis

Top Keywords

thrombophlebitis pregnancy
4
thrombophlebitis
1

Similar Publications

Abnormal microRNA expression profile at early stages of gestation in pregnancies destined to develop placenta previa.

Front Med (Lausanne)

December 2024

Institute for the Care of the Mother and Child, Third Faculty of Medicine, Charles University, Prague, Czechia.

Article Synopsis
  • Placenta previa is a condition where the placenta implants abnormally in the lower uterus, leading to serious risks for both the mother and fetus, including hemorrhage and stillbirth.
  • This study focused on analyzing microRNA expression in the blood during the first trimester of pregnancies that later developed placenta previa, comparing them to normal pregnancies.
  • The results showed that several microRNAs were downregulated in those pregnancies, with a combination of seven specific microRNAs accurately distinguishing between healthy and placenta previa pregnancies early on.
View Article and Find Full Text PDF
Article Synopsis
  • Foot and ankle disorders are frequent during pregnancy due to changes in weight, hormones, and fluid balance, leading to issues like varicose veins, DVT, and tendon injuries.* -
  • Ultrasound is highlighted as a safe and non-invasive diagnostic tool, particularly effective for assessing venous conditions and differentiating causes of edema; it provides real-time imaging without radiation.* -
  • The technology also aids in diagnosing musculoskeletal problems and detecting foreign bodies, making it a cost-effective and accessible option for improving patient outcomes in pregnant women.*
View Article and Find Full Text PDF

Septic pelvic thrombophlebitis (SPT) is a rare condition that forms thrombosis in the pelvic veins, typically the ovarian veins, with subsequent infection and inflammation. We present a case of right ovarian vein thrombosis (ROVT), methicillin-resistant Staphylococcus aureus (MRSA) bacteremia, and delayed onset of SPT symptoms, requiring tissue-plasminogen activator. A 40-year-old woman, G3P2, at 38 weeks' gestation, was admitted with a fever of 39°C.

View Article and Find Full Text PDF

[Maternal mortality due to venous thromboembolism in France 2016-2018].

Gynecol Obstet Fertil Senol

April 2024

Département de Maïeutique UFR Simone Veil-Santé, université de Versailles Saint-Quentin en Yvelines - Paris Saclay, Montigny-le-Bretonneux, France; Service de gynecologie - obstétrique, centre hospitalier de Rambouillet, Rambouillet, France.

Pregnancy and the post-partum period represent a thromboembolic risk situation, with pulmonary embolism (PE) remaining one of the leading causes of direct maternal deaths in developed countries. Between 2016 and 2018 in France, twenty maternal deaths were caused by venous thromboembolic complications (VTE), yielding a Maternal Mortality Ratio (MMR) of 0.9 per 100,000 live births (95%CI 0.

View Article and Find Full Text PDF

[Maternal mortality by stroke in France 2016-2018].

Gynecol Obstet Fertil Senol

April 2024

Service de réanimation polyvalente, pôle de soins critiques, hôpital de Lens, 62307 Lens, France.

Between 2016 and 2018, twenty maternal deaths were associated with a stroke. The 20 deaths whose main cause was stroke represent 7.4% of all maternal deaths, i.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!